|
Volumn 6, Issue 7, 1996, Pages 885-888
|
Novel 4,4-bis(trifluoromethyl) imidazolines as stereospecific and orally active acyl CoA: Cholesterol acyltransferase (ACAT) inhibitors and antihypercholesterolemic agents
|
Author keywords
[No Author keywords available]
|
Indexed keywords
5 [N (4 CYANOBENZOY) N METHYLAMINO] 2 (4 CYANOPHENYL) 4,4 BIS(TRIFLUOROMETHYL 4,5 DIHYDROIMIDAZOLE;
ANTILIPEMIC AGENT;
CHOLESTEROL ACYLTRANSFERASE;
CHOLESTEROL ACYLTRANSFERASE INHIBITOR;
IMIDAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
BIOAVAILABILITY;
CELL LINE;
CHOLESTEROL BLOOD LEVEL;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENANTIOMER;
ENZYME INHIBITION;
MACROPHAGE;
MOLECULAR MODEL;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
RABBIT;
ANIMALIA;
ORYCTOLAGUS CUNICULUS;
|
EID: 0029921270
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/0960-894X(96)00137-0 Document Type: Article |
Times cited : (9)
|
References (20)
|